Insider Transactions in Q1 2025 at Myriad Genetics Inc (MYGN)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 25
2025
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
362
-0.78%
|
$3,258
$9.73 P/Share
|
|
Mar 24
2025
|
Paul J Diaz President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
45,139
-2.44%
|
$406,251
$9.98 P/Share
|
|
Mar 24
2025
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,701
-0.35%
|
$24,309
$9.98 P/Share
|
|
Mar 24
2025
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,345
-0.39%
|
$12,105
$9.98 P/Share
|
|
Mar 24
2025
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,901
-0.8%
|
$26,109
$9.98 P/Share
|
|
Mar 24
2025
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
982
-1.04%
|
$8,838
$9.98 P/Share
|
|
Mar 22
2025
|
Paul J Diaz President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
72,541
-3.65%
|
$725,410
$10.01 P/Share
|
|
Mar 22
2025
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,989
-0.64%
|
$49,890
$10.01 P/Share
|
|
Mar 22
2025
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,345
-2.05%
|
$73,450
$10.01 P/Share
|
|
Mar 22
2025
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,187
-1.66%
|
$61,870
$10.01 P/Share
|
|
Mar 22
2025
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,563
-1.6%
|
$15,630
$10.01 P/Share
|
|
Mar 22
2025
|
Margaret Ancona SVP, Chief of Staff |
SELL
Payment of exercise price or tax liability
|
Direct |
2,622
-1.0%
|
$26,220
$10.01 P/Share
|
|
Mar 15
2025
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,764
-2.58%
|
$47,640
$10.07 P/Share
|
|
Mar 15
2025
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,335
-1.75%
|
$33,350
$10.07 P/Share
|
|
Mar 15
2025
|
Margaret Ancona SVP, Chief of Staff |
SELL
Payment of exercise price or tax liability
|
Direct |
1,572
-1.18%
|
$15,720
$10.07 P/Share
|
|
Mar 15
2025
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
684
-1.38%
|
$6,840
$10.07 P/Share
|
|
Mar 15
2025
|
Paul J Diaz President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
30,118
-2.9%
|
$301,180
$10.07 P/Share
|
|
Mar 15
2025
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,729
-0.94%
|
$37,290
$10.07 P/Share
|
|
Mar 14
2025
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,544
-4.41%
|
$85,440
$10.07 P/Share
|
|
Mar 14
2025
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,390
-2.25%
|
$43,900
$10.07 P/Share
|
|
Mar 14
2025
|
Shereen Solaiman Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,060
-5.18%
|
$60,600
$10.07 P/Share
|
|
Mar 14
2025
|
Margaret Ancona SVP, Chief of Staff |
SELL
Payment of exercise price or tax liability
|
Direct |
3,417
-2.51%
|
$34,170
$10.07 P/Share
|
|
Mar 14
2025
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
855
-1.69%
|
$8,550
$10.07 P/Share
|
|
Mar 14
2025
|
Paul J Diaz President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
37,564
-3.49%
|
$375,640
$10.07 P/Share
|
|
Mar 14
2025
|
Samraat S. Raha Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,649
-1.56%
|
$76,490
$10.07 P/Share
|
|
Mar 14
2025
|
Scott J. Leffler Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,217
-2.77%
|
$62,170
$10.07 P/Share
|
|
Mar 14
2025
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,847
-1.46%
|
$58,470
$10.07 P/Share
|
|
Mar 13
2025
|
Jennifer Lynne Fox Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63,145
+33.58%
|
-
|
|
Mar 13
2025
|
Dale Muzzey Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,773
+28.14%
|
-
|
|
Mar 13
2025
|
Kevin Richard Haas Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
54,124
+21.69%
|
-
|
|
Mar 13
2025
|
Shereen Solaiman Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63,145
+35.05%
|
-
|
|
Mar 13
2025
|
Margaret Ancona SVP, Chief of Staff |
BUY
Grant, award, or other acquisition
|
Direct |
54,124
+28.42%
|
-
|
|
Mar 13
2025
|
Natalie Munk Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+7.33%
|
-
|
|
Mar 13
2025
|
Samraat S. Raha Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
216,495
+30.69%
|
-
|
|
Mar 13
2025
|
Scott J. Leffler Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
72,165
+24.32%
|
-
|
|
Mar 13
2025
|
Mark Verratti Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
99,227
+19.83%
|
-
|
|
Mar 01
2025
|
Shereen Solaiman Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,912
-3.43%
|
$19,120
$10.73 P/Share
|
|
Feb 25
2025
|
Margaret Ancona SVP, Chief of Staff |
SELL
Payment of exercise price or tax liability
|
Direct |
2,697
-3.44%
|
$29,667
$11.74 P/Share
|
|
Feb 25
2025
|
Kevin Richard Haas Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,016
-0.78%
|
$11,176
$11.74 P/Share
|
|
Feb 07
2025
|
Paul J Diaz President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
114,828
+9.63%
|
-
|
|
Feb 07
2025
|
Mark Verratti Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,758
+4.05%
|
-
|
|
Feb 07
2025
|
Dale Muzzey Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,622
+8.27%
|
-
|
|
Feb 07
2025
|
Kevin Richard Haas Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,758
+8.28%
|
-
|
|
Feb 07
2025
|
Margaret Ancona SVP, Chief of Staff |
BUY
Grant, award, or other acquisition
|
Direct |
6,468
+7.3%
|
-
|
|
Feb 07
2025
|
Natalie Munk Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,316
+6.65%
|
-
|
|
Jan 29
2025
|
Scott J. Leffler Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,230
-7.43%
|
$146,760
$12.54 P/Share
|
|
Jan 01
2025
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
417
-0.39%
|
$5,421
$13.71 P/Share
|